Positron Corporation and Disease Management have announced an agreement to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.??
The product will include a heart disease pre-test risk calculator; a Coronary Disease Reversal and Prevention practice management program; a web-based, patient-centric, disease-reversal and life-style modification program; an interpreting and referring physician portal as well as a cost-efficacy and patient-outcomes tracker, according to the Houston-based Positron.??
“The development of our heart disease management solution will help us reach beyond our current molecular imaging targeted business to offer a product to payors, self insured corporations, multi-specialty groups, cardiology groups, hospitals and finally direct to the consumer,” said Joseph G. Oliverio, president of Positron.